InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (5 ops.)
Discover the detailed record of transactions filed by DeLuca Teresa, Director. Officer active across 2 companies, notably Surgery Partners, Inc.. Aggregated, 10 disclosures have been logged. Total volume traded: €1.1m. The latest transaction was disclosed on 20 May 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations10 total
€151,2354,030 shares@ €37.52720.0083% mcap12.8% of flow
Common Stock
SEC:0001638833-22-000111:0·
€74,6141,535 shares@ €48.60850.0041% mcap6.3% of flow
Common Stock
SEC:0001638833-22-000081:0·
€17,6285,000 shares@ €3.5256100.0% of flow
Common Stock
SEC:0001213900-21-064878·
Ideal exit: 5 Sept 2022 (T+270)
€17,6285,000 shares@ €3.525650.0% of flow
Common Stock
SEC:0001213900-21-064878:0·
Ideal exit: 5 Sept 2022 (T+270)
€79,6702,000 shares@ €39.83510.0044% mcap16.6% of flow
Common Stock
SEC:0001638833-21-000138·
Ideal exit: 7 May 2022 (T+270)
€79,6702,000 shares@ €39.83510.0044% mcap6.7% of flow
Common Stock
SEC:0001638833-21-000138:0·
Ideal exit: 7 May 2022 (T+270)
€263,1575,035 shares@ €52.26560.014% mcap22.2% of flow
Common Stock
SEC:0001638833-21-000130:0·
€263,1575,035 shares@ €52.26560.014% mcap54.9% of flow
Common Stock
SEC:0001638833-21-000130·
€136,3782,633 shares@ €51.79560.0075% mcap28.5% of flow
Common Stock
SEC:0001638833-21-000128·
€136,3782,633 shares@ €51.79560.0075% mcap11.5% of flow
Common Stock
SEC:0001638833-21-000128:0·
10 of 10 declarations
About DeLuca Teresa
Teresa DeLuca serves as a Board Member at Surgery Partners, Inc. and 180 Life Sciences Corp. She brings expertise in business management and market strategy, contributing to the strategic direction of these companies. As a board member, she is involved in key decision-making processes that influence the performance of Surgery Partners and 180 Life Sciences. Her experience in the sector allows her to inform discussions on innovation and growth.
